Identification of a domain in the β subunit of the type I interferon (IFN) receptor that exhibits a negative regulatory effect in the growth inhibitory action of type I IFNs

Leonidas C. Platanias, Paul Domanski, Owen W. Nadeau*, Taolin Yi, Shahab Uddin, Eleanor Fish, Benjamin G. Neel, Oscar R. Colamonici

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Expression of human α and long form of the β (β(L)) subunits of type I interferon receptor (IFN-R) in mouse cells is sufficient to activate the Jak-Stat pathway and to elicit an antiviral state in response to human IFNα2 and IFNβ. We demonstrate herein, however, that these cells respond to the antiproliferative effects of murine IFNαβ but not human type I IFNs. These results suggest that an unknown species-specific component is required for the antiproliferative effect of human type I IFNs. The absence of this component can be complemented by expressing the human β(L) chain truncated at amino acid 346. Thus, the distal region of β(L) appears to function as a negative regulator of the growth inhibitory effects of type I IFNs. Further studies looking for possible targets of the β(L) regulatory domain demonstrated that this region associates with a tyrosine phosphatase. These results suggest that a protein associated with the negative N regulatory domain of β(L), likely a tyrosine phosphatase, plays a role in regulating the growth inhibitory effects of human type I IFNs.

Original languageEnglish (US)
Pages (from-to)5577-5581
Number of pages5
JournalJournal of Biological Chemistry
Volume273
Issue number10
DOIs
StatePublished - Mar 6 1998

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Identification of a domain in the β subunit of the type I interferon (IFN) receptor that exhibits a negative regulatory effect in the growth inhibitory action of type I IFNs'. Together they form a unique fingerprint.

Cite this